MAPK3 and Miyoshi myopathy: These interactions between infiltrating TAMs and myeloma cells resulted in activation of non-receptor tyrosine kinase Src, Erk1/2 kinases and c-myc activation in MM cells, all of which have been shown to promote MM cell survival and drug resistance [69,70].